Invert Arenicin-1 (13-21)-Orn-Dap + Invert Arenicin-1 (13-21)

General Information


DRACP ID  DRACP03841

Peptide Name   Invert Arenicin-1 (13-21)-Orn-Dap + Invert Arenicin-1 (13-21)

Sequence  WCRRYRVLVXX,WCRRYRVLV

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C114H174N38O18S2

Absent amino acids  ADEFGHIKMNPQST

Common amino acids  R

Mass  300590

Pl  11.82

Basic residues  6

Acidic residues  0

Hydrophobic residues  8

Net charge  6

Boman Index  -5658

Hydrophobicity  -9.52

Aliphatic Index  92.38

Half Life 
  /

Extinction Coefficient cystines  14105

Absorbance 280nm  705.25

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31234579

Title  Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13513

DRACP is developed by Dr.Zheng's team.